HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ulrika Bitzén Selected Research
Ulrika Bitzén Research Topics
Disease
2
Prostatic Neoplasms (Prostate Cancer)
04/2021 - 05/2020
1
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency
01/2021
1
Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2021
1
Adrenal Rest Tumor
01/2021
1
Myelolipoma
01/2021
1
Lung Neoplasms (Lung Cancer)
09/2019
1
Neoplasms (Cancer)
07/2019
1
Head and Neck Neoplasms (Head and Neck Cancer)
04/2016
1
Pulmonary Atelectasis
03/2006
1
Pulmonary Embolism
02/2006
Drug/Important Bio-Agent (IBA)
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2021 - 07/2019
2
Silicon
IBA
09/2019 - 07/2019
1
Biomarkers (Surrogate Marker)
IBA
04/2021
1
Prostate-Specific Antigen (Semenogelase)
IBA
04/2021
1
Glucocorticoids
IBA
01/2021
1
Prednisolone (Predate)
FDA Link
Generic
01/2021
1
metomidate
IBA
01/2021
1
Androgens
IBA
01/2021
1
Cosyntropin (Cortrosyn)
FDA Link
Generic
01/2021
1
Salts
IBA
01/2021
1
Antigens
IBA
05/2020
1
Tinzaparin (Innohep)
FDA Link
02/2006
Therapy/Procedure
2
Radiotherapy
04/2021 - 04/2016
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2021
1
Adrenalectomy
01/2021
1
Positive-Pressure Respiration (Positive End-Expiratory Pressure)
03/2006
1
Therapeutics
02/2006